Literature DB >> 19122061

An expedited palliative radiation protocol for lytic or proliferative lesions of appendicular bone in dogs.

Heather M Knapp-Hoch1, Janean Louise Fidel, Rance K Sellon, Patrick R Gavin.   

Abstract

Fifty-eight dogs with lytic or proliferative bone lesions were treated with a radiation protocol of two 8-Gy fractions over 2 consecutive days. The protocol was well tolerated, with no increase in early or late effects over previously published protocols. Forty-three (91%) of 47 dogs responded positively to radiation, with a median time of 2 days to onset of pain relief. Median duration of pain relief was 67 days (range 12 to 503 days; mean 99+/-16 days). Median survival time for all dogs was 136 days (mean 179+/-18 days). Distal radial location was a positive prognostic indicator for survival (P=0.005).

Entities:  

Mesh:

Year:  2009        PMID: 19122061     DOI: 10.5326/0450024

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  4 in total

1.  Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).

Authors:  Beck Ringdahl-Mayland; Douglas H Thamm; Tiffany W Martin
Journal:  Front Vet Sci       Date:  2022-05-10

2.  Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.

Authors:  Megan E Duffy; Christie L Anderson; Kevin Choy; Janean L Fidel
Journal:  Can Vet J       Date:  2018-02       Impact factor: 1.008

3.  Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs.

Authors:  Tiffany Wormhoudt Martin; Lynn Griffin; James Custis; Stewart D Ryan; Mary Lafferty; Mary-Keara Boss; Daniel Regan; Sangeeta Rao; Del Leary; Stephen J Withrow; Susan M LaRue
Journal:  Vet Comp Oncol       Date:  2021-01-13       Impact factor: 2.385

4.  Vitamin d receptor, retinoid x receptor, ki-67, survivin, and ezrin expression in canine osteosarcoma.

Authors:  John Davies; Heather Heeb; Rama Garimella; Kimberly Templeton; David Pinson; Ossama Tawfik
Journal:  Vet Med Int       Date:  2012-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.